Outcomes | Overall | No bleeding in early pregnancy | Bleeding in early pregnancy | ||
---|---|---|---|---|---|
Non-treatment | Progesterone treatment | Non-treatment | Progesterone treatment | ||
Very preterm (< 34 weeks of gestation) | |||||
N (%) | 47(0.7) | 21(0.4) | 3(0.8) | 14(1.9) | 9(1.3) |
Adjusted model I* | 1 | 1.69(0.49–5.78) | 4.16(2.09–8.26) | 2.73(1.24–6.05) | |
Adjusted model IIa | 1 | 1.74(0.51–5.98) | 4.25(2.13–8.49) | 2.79(1.26–6.18) | |
Preterm (< 37 weeks of gestation) | |||||
N (%) | 261(4.0) | 155(3.2) | 16(4.3) | 52(7.0) | 38(5.6) |
Adjusted model I* | 1 | 1.32(0.78–2.25) | 2.18(1.57–3.02) | 1.74(1.20–2.51) | |
Adjusted model IIa | 1 | 1.35(0.79–2.30) | 2.21(1.59–3.07) | 1.74(1.21–2.52) | |
SGA | |||||
N (%) | 430(6.5) | 300(6.2) | 25(6.7) | 51(6.9) | 54(8.0) |
Adjusted model I* | 1 | 1.17(0.77–1.80) | 1.20(0.88–1.63) | 1.44(1.06–1.96) | |
Adjusted model IIb | 1 | 1.19(0.77–1.82) | 1.23(0.89–1.68) | 1.46(1.07–1.98) | |
LBW | |||||
N (%) | 167(2.5) | 94(2.0) | 10(2.7) | 32(4.3) | 31(4.6) |
Adjusted model I* | 1 | 1.44(0.74–2.80) | 2.30(1.52–3.45) | 2.44(1.60–3.70) | |
Adjusted model IIb | 1 | 1.39(0.61–3.16) | 1.15(0.65–2.01) | 2.10(1.25–3.51) | |
WAZ < -1 at 12 months of age (n = 3181) | |||||
N (%) | 99(3.1) | 67(2.9) | 3(1.7) | 13(3.6) | 16(5.1) |
Adjusted model I* | 1 | 0.61(0.19–1.97) | 1.27(0.69–2.34) | 1.84(1.05–3.24) | |
Adjusted model IIc | 1 | 0.61(0.19–2.00) | 1.11(0.60–2.13) | 1.79(1.01–3.19) |